Digital health company, NeurodigitX reported on Wednesday the launch of Plastic Health platform, which allows a powerful mainstream bloodless assessment of inflammation levels in the current COVID-19 pandemic to enhance vaccine immunization strategies.

The company reportedly collects HRV, respiratory and cognitive data with the Plastic Egg, a biosensor and breathing-based game controller and Plastic mobile games guiding user's breath to measure inflammation accurately. Repeated gameplay allows profiling of slowly evolving (stress, chronic disease) and rapid changes (virus exposure, immunization) in inflammation status.

According to the company, it provides the only protocol-controlled, high-resolution, longitudinal, individualized routine measure of HRV and brain plasticity to closely track inflammation status. The Plastic Health reveals a draining of plasticity reserve, reflecting inflammation changes.

Nearly 50,000 scientific studies have been released on HRV (Heart Rate Variability), which affords a noninvasive assessment of inflammation of brain and bodily function. The company's Plastic Health combines individualized assessment and the heatmapping of public health. COVID-19 infection shows sudden inflammation change, further altered by the negative impact of cumulative stress.